검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Triamcinolone |
Overview Company | Novartis |
Overview Modality | ANTIBODY |
Overview Target | Diabetic Macular Edema |
Overview Indication | Psoriasis; Atopic Dermatitis |
Overview Phase | APPROVED |
Overview Status | ACTIVE |
MoA Mechanism | targeting of STING-TBK1 signaling |
MoA Biomarker | biomarkers have shown that both TA and DEX implant are effective in promoting scattered punctate and plaque-l |
PK/PD Species | Rabbit |
PK/PD Animal (cat.) | Unknown |
PK/PD Experiment | pd |
Toxicology Species | Rabbit |
Toxicology Animal (cat.) | Unknown |
Toxicology Major finding | A Randomized Controlled Phase 3 Trial of Oral Prednisolone Administration Versus Local Triamcinolone Injection Therapy for Esophageal Stricture Prevention After Extensive Endoscopic Submucosal Dissection (JCOG1217).. Endoscopic local triamcinolone injection is a standard therapy for esophageal stricture (ES) prevention after extensive endoscopic submucosal dissection (ESD); however, oral prednisol… |
Clinical Primary efficacy | ORR 9.8% |
Clinical ORR | 9.8% |
Clinical Result source | ClinicalTrials.gov NCT03520387 |
Clinical Data Tier / Score | A · 43 |
Clinical Program phase | APPROVED |
Clinical Clinical sync | 2026년 7월 12일 (2일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Triamcinolone |
Overview Company | Novartis |
Overview Modality | ANTIBODY |
Overview Target | Diabetic Macular Edema |
Overview Indication | Psoriasis; Atopic Dermatitis |
Overview Phase | APPROVED |
Overview Status | ACTIVE |
MoA Mechanism | targeting of STING-TBK1 signaling |
MoA Biomarker | biomarkers have shown that both TA and DEX implant are effective in promoting scattered punctate and plaque-l |
PK/PD Species | Rabbit |
PK/PD Animal (cat.) | Unknown |
PK/PD Experiment | pd |
Toxicology Species | Rabbit |
Toxicology Animal (cat.) | Unknown |
Toxicology Major finding | A Randomized Controlled Phase 3 Trial of Oral Prednisolone Administration Versus Local Triamcinolone Injection Therapy for Esophageal Stricture Prevention After Extensive Endoscopic Submucosal Dissection (JCOG1217).. Endoscopic local triamcinolone injection is a standard therapy for esophageal stricture (ES) prevention after extensive endoscopic submucosal dissection (ESD); however, oral prednisol… |
Clinical Primary efficacy | ORR 9.8% |
Clinical ORR | 9.8% |
Clinical Result source | ClinicalTrials.gov NCT03520387 |
Clinical Data Tier / Score | A · 43 |
Clinical Program phase | APPROVED |
Clinical Clinical sync | 2026년 7월 12일 (2일 전) |
추천 비교
추천 비교